Early prediction of cardiac resynchronization therapy response by non-invasive electrocardiogram markers

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Diagnostics

Background:

• Cardiac resynchronization therapy (CRT) is a key treatment for severe heart failure.
• Approximately one-third of patients do not respond to CRT, impacting its effectiveness and cost.
• Predicting CRT response is crucial for optimizing patient outcomes.

Purpose of the Study:

• To evaluate a novel surface electrocardiogram (ECG) marker for predicting CRT response.
• To assess the marker's performance in conjunction with QRS duration.

Main Methods:

• Retrospective study of 43 heart failure patients undergoing CRT.
• Extraction and spectral analysis of QRST complexes to derive an energy measure.
• Evaluation of the novel ECG marker combined with QRS duration for predictive performance.

Main Results:

• The novel ECG marker showed significantly lower values in CRT non-responders.
• Combined with QRS duration, the marker achieved 86% accuracy, 88% sensitivity, and 80% specificity in predicting CRT response.
• This combination offers improved non-invasive prediction of CRT success.

Conclusions:

• The proposed novel ECG marker is a promising tool for predicting cardiac resynchronization therapy response.
• Integrating this marker may help clinicians identify suitable candidates for CRT, minimizing unsuccessful interventions.
• Further validation could enhance the utility and cost-effectiveness of CRT.